Contact Us

Research & Evidence

Scientific Publications

Scientific Publications

Decades of peer-reviewed foundational research and clinical
validation proving the efficacy of our translational platforms.

Decades of peer-reviewed foundational research and clinical validation proving the efficacy of our translational platforms.

All Publications
Genetix
MeMoSA®
Cancer Vaccine
Others

MeMoSA®

2026

MeMoSA dataset: A multi-country collection of over 30,000 oral mucosa images with clinically labelled lesions.

Chew, S., Nabil, A., Sin, W.J. et al.

Scientific Data

|

https://doi.org/10.1038/s41597-026-06998-7

View Publication

Cancer Vaccine

2025

Cancer vaccine overcomes immune evasion of nasopharyngeal carcinoma by restoring MHC-I through transcriptional regulation of NLRC5.

Gan, Chai Phei et al.

Journal of translational medicine vol. 23,1 1414

|

doi:10.1186/s12967-025-07418-x

View Publication

Genetix

2025

Exploring willingness to pay out-of-pocket for genetic testing among ovarian cancer patients in Malaysia, a middle-income country in Asia.

Padmanabhan, Heamanthaa et al.

Journal of gynecologic oncology

|

doi:10.3802/jgo.2026.37.e32

View Publication
Load More Publications

Genetix

2025

Exploring willingness to pay out-of-pocket for genetic testing among ovarian cancer patients in Malaysia, a middle-income country in Asia.

Padmanabhan, Heamanthaa et al.

Journal of gynecologic oncology

|

doi:10.3802/jgo.2026.37.e32

View Publication

Genetix

2022

Oncologist-led BRCA counselling improves access to cancer genetic testing in middle-income Asian country, with no significant impact on psychosocial outcomes.

Yoon, Sook-Yee et al.

Journal of medical genetics vol. 59

|

doi:10.1136/jmedgenet-2020-107416

View Publication

Genetix

2022

Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low-to-middle income Asian country.

Lee, Yong-Quan et al.

Journal of genetic counseling vol. 31

|

doi:10.1002/jgc4.1579

View Publication

MeMoSA®

2026

MeMoSA dataset: A multi-country collection of over 30,000 oral mucosa images with clinically labelled lesions.

Chew, S., Nabil, A., Sin, W.J. et al.

Scientific Data

|

https://doi.org/10.1038/s41597-026-06998-7

View Publication

MeMoSA®

2023

High referral accuracy for oral cancers and oral potentially malignant disorders using telemedicine.

Haron, Nabihah et al.

Oral Diseases, vol. 29, no. 2

|

doi:10.1111/odi.13892

View Publication

MeMoSA®

2022

Accelerated implementation of teleconsultation services for the monitoring of oral potentially malignant disorders as a result of the COVID-19 pandemic.

Rajendran, Senthilmani et al.

Oral oncology vol. 126

|

doi:10.1016/j.oraloncology.2022.105730

View Publication
Load More Publications

Cancer Vaccine

2025

Cancer vaccine overcomes immune evasion of nasopharyngeal carcinoma by restoring MHC-I through transcriptional regulation of NLRC5.

Gan, Chai Phei et al.

Journal of translational medicine vol. 23,1 1414

|

doi:10.1186/s12967-025-07418-x

View Publication

Cancer Vaccine

2021

Monitoring T Cells Responses Mounted by Therapeutic Cancer Vaccines.

Lim, Kue Peng, and Nur Syafinaz Zainal.

Frontiers in molecular biosciences vol. 8 623475

|

doi:10.3389/fmolb.2021.623475

View Publication

Cancer Vaccine

2021

DNA Vaccines Targeting Novel Cancer-Associated Antigens Frequently Expressed in Head and Neck Cancer Enhance the Efficacy of Checkpoint Inhibitor.

Wang, Chuan et al.

Frontiers in immunology vol. 12 763086

|

doi:10.3389/fimmu.2021.763086

View Publication
Load More Publications
Make an Inquiry